meta_pixel
Tapesearch Logo
Log in
Science Quickly

Medical Marijuana Faces Fed's Catch-22

Science Quickly

Scientific American

Science

4.41.4K Ratings

🗓️ 27 February 2017

⏱️ 2 minutes

🧾️ Download transcript

Summary

Doing large studies of marijuana's potential as medicine means getting it removed from an official federal list of substances with no official medical use—which requires more proof of its potential as medicine. Learn more about your ad choices. Visit megaphone.fm/adchoices

Transcript

Click on a timestamp to play from that location

0:00.0

This is a scientific Americans 60 second science.

0:04.7

I'm Steve Mursky.

0:05.8

Got a minute?

0:06.8

Medical marijuana is now available in 28 states,

0:11.5

but a big obstacle to research on marijuana as medicine is that it's listed

0:15.8

by the federal government on what's called Schedule 1.

0:19.1

Assignment to Schedule 1 means that the Food and Drug Administration does not recognize a legitimate medical purpose to a substance.

0:27.0

At a session on medical marijuana at the annual meeting of the American Association for the Advancement of Science on February 19th, I asked researcher

0:35.6

Ryan Vandry of the Johns Hopkins University School of Medicine about getting marijuana off

0:41.7

of the list of Schedule 1 substances?

0:44.0

Well, it can't come off of Schedule 1 to a different schedule

0:48.0

until the traditional drug development work has been done.

0:52.0

And I don't think the traditional drug development work really can be done

0:56.7

while it's Schedule 1.

0:58.1

It just makes large phase three trials in hospital-based programs near impossible.

1:04.0

It's a catch-22.

1:05.2

So I think the only way to really get around that is kind of two paths.

1:08.8

One, you just unscheduled it completely.

1:12.1

Alcohol is not scheduled, for example example and so that's the pathway

1:15.1

that some of the states have gone just making it available or treating as it as a

1:20.2

like a botanical herbal product. The other way would be to kind of wait until we

1:27.1

get more targeted specific products. So not whole plant cannabis but maybe more

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Scientific American, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Scientific American and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.